A new study out of UC Davis suggests that increased access to cannabis stores that legally sell medical and recreational cannabis may help to reduce opioid-related deaths.
The breakthrough, developed by Korean scientists, is likely to revolutionize testing as existing methods are not only inaccurate but can result in over-diagnosis and necessitate invasive biopsies.
German researchers have enabled mice paralyzed after spinal cord injuries to walk again, re-establishing a neural link hitherto considered irreparable in mammals.
The monthly injection treatment replaces the need for some to take daily pills. The company says the price of the injections is comparable to the cost of the pill versions.
Named the Center for Psychedelic Psychotherapy and Trauma Research the institution is first focusing on MDMA-assisted psychotherapy for PTSD.
Progress has been made globally on eight of 12 key indicators. The Gambia, Nepal, Sierra Leone, Ethiopia and Tunisia shown particularly notable improvement.
Cannabis is no longer classified as a Schedule IV drug as per WHO’s recommendation. The declassification opens up the door for more research into its medicinal and therapeutic uses.
The Phase 1 trial, led by researchers from the Icahn School of Medicine at Mount Sinai, found this experimental vaccine to be both safe and effective at generating a long-term immune response in a small number of healthy adults.
A first-of-its-kind exploratory study, led by researchers from Yale School of Medicine, has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for a least two weeks.
Over the last 20 years, however, the number of people infected has dropped by 74%, from 199 million to 51.4 million, and last year three countries—Malawi, Kiribati, and Yemen—eliminated it altogether.
